Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?
This article was originally published in The Pink Sheet Daily
Executive Summary
The decision is part of a broader corporate R&D restructuring plan, and Lilly will continue some of its priority projects at its Indianapolis headquarters.